Position in CVM
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$7
-$15 QoQ
Shares Held
7
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#36
of 41 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CVM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026JPMORGAN CHASE & CO holds $12,919,879,903 across 425 Biotechnology names. CVM ranks #411 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,517,600 | $3,237,487,438 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,774,199 | $2,353,364,036 | |
| 3 | INSM |
INSMED Inc
|
10,428,170 | $1,111,851,478 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,675,517 | $805,410,876 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
3,298,066 | $617,661,794 | |
| 6 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
2,652,746 | $294,534,385 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
1,160,786 | $279,714,596 | |
| 8 | QURE |
uniQure N.V.
|
4,867,755 | $224,208,791 |
All Filings in CVM
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7 | 7 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $22 | 7 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $8,767 | 1,667 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $64 | 7 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $45 | 20 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $611 | 2,661 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $4,178 | 10,449 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $274 | 259 | Shares | Defined | 2024-12-26 | |
| 2024-06-30 | $300 | 259 | Shares | Defined | 2024-12-26 | |
| 2024-03-31 | $494 | 259 | Shares | Defined | 2024-12-26 | |
| 2023-12-31 | $704 | 259 | Shares | Defined | 2024-12-26 | |
| 2023-09-30 | $323 | 259 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $624 | 259 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $600 | 259 | Shares | Defined | 2023-05-18 | |
| 2022-12-31 | $1 | 259 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $800 | 259 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,165 | 259 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $67,991 | 17,301 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $101,727 | 14,328 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $1,105,240 | 100,568 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $202,285 | 23,305 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $341,296 | 22,439 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $177,721 | 15,242 | Shares | Defined | 2021-02-19 | |
| 2020-09-30 | $160,356 | 12,577 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $165,924 | 11,121 | Shares | Defined | 2020-08-11 | |
| 2020-03-31 | $122,877 | 10,648 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||